市况评论

作者

倪国权先生 (Alex Ni)
助理经理

曾任职钢材交易员及广告公司主任,所以特别喜欢研究资源类及消费类股票。欢迎来电赐教或交流心得。
电话:
22776779

Modern Dental Group Limited (3600.HK)

2019年6月25日 星期二 观看次数763

Stock Commentary                                     Date: 18/6/2019

        

Stock:                                                     Modern Dental Group Limited

Closing price:                                      $1.46 (18/02/2019)

52 weeks range:                                         $1.186 - $2.017

Shares outstanding:                               986,746,000

Market Capitalization:                         HK$ 1.233 Billion

Target Price (12 months):                        No Target

 

Summary :

  1. The group is in the transition phase period, consolidating their business through various acquisitions.
  2. The incurred loss was from restructuring, re-financing and currency exchange. The group’s core business remained relatively stable.
  3. The group’s prospect came from local market penetration through their strategic geographical acquisitions.
  4. Greater China may be the company’s next sales engine as GDP per capita increased, so was the demand for high quality medical/dental care products.

 

Closer Look of 2018 and beyond:

1.

A. The group’s total sales in dollar value as well as volume record a slight increase; notably, dollar unit of each item also record an increase over the past year.

 

2.

B. The group’s main sale driver came from “Fixed prosthetic devices”. As pointed out from the group’s annual report, the group will continue to focus on high value products in order increase their profit margin.

 

3.

C. European market continued to be the main sales driver of the group’s revenue, while greater China market continued to grow. Recent acquisition in USA would take time to consolidate.

4. Further analysis will be give after the next quarter result in order to get a closer look of the group’s performance.

 

「注:本人倪国权为证监会持牌人士。截至本评论文章发表日止,本人及/或其有联系者并无持有全部提及之证券的所有相关财务权益。」; Or
” I, Ni Kwok Kuen Alex, am a licensed person under the Securities and Futures Commission. Until the date this commentary was published, neither I and/or my affiliates are the beneficiary of the securities mentioned herein or are entitled to any financial interests in relation thereto. “

 

 

研究报告由辉立证券集团旗下于香港证监会持牌的辉立证券(香港)有限公司及/或辉立商品有限公司(「辉立」)所发报。本文所包含的资料均为辉立从相信为准确的来源搜集。辉立对有关报告所引致之任何损失或亏损概不负责。本报告所载的资料只供参考用途,并没有法律约束力,亦不构成投资建议,邀约,购入,出售任何产品。
投资涉及风险,有可能损失投资本金。你应该咨询专业人士,就本身的投资经验,财务状况,个人目标及风险取向,以提供投资意见。各类产品的风立,请参阅本公司网页http://www.phillip.com.hk「风险披露声明」。
辉立(或其雇员)可能持有本文所述有关的投资产品。此外,辉立(或任何附属公司)随时可能替向报告内容所述及的公司提供服务,招揽或业务往来。
以上资料为辉立拥有并受版权及知识产法保护。除非事先得到辉立明确书面批准,否则不应复制,散播或发布。
返回页首
联络我们
请即联络你的客户主任或致电我们。
研究部
电话 : (852) 2277 6846
传真 : (852) 2277 6565
电邮 : businessenquiry@phillip.com.hk

查询及支援
分行资料
投诉程序
查数网
登入
黄师傅每日讲股
研究部快讯
免费订阅
联络我们